Time-Restricted Eating for Type II Diabetes: TRE-T2D (TRE-T2D)
Feasibility and Efficacy of Time-Restricted Eating in Diabetes Management
Sponsor: Salk Institute for Biological Studies
Listed as NCT05365529, this NA trial focuses on Diabetes Mellitus, Type 2 and Diabetes Type2 and remains actively recruiting participants. Sponsored by Salk Institute for Biological Studies, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Nov 2024 — Present [monthly]
Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Sep 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jul 2022 — Sep 2023 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jun 2022 — Jul 2022 [monthly]
Recruiting NA
First recorded
May 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Salk Institute for Biological Studies
- University of California, San Diego
For direct contact, visit the study record on ClinicalTrials.gov .